ArticleESMO real world data and digital oncology2025

Local and central testing for HER2, PD-L1, MSI/MMR, EBV, and CLDN18.2 in advanced gastric cancer: results from the SAPHIR registry.

K Potthoff et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.